SARAH TROMBETTA: Open Payments
NPI 1760968085 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,909 in 98 payments from 18 companies in 2025. Trend: 2023 $187 · 2024 $1,331 · 2025 $1,909
Food & beverage: $1,817Education: $92
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $320 |
| GENZYME CORPORATION | 16 | $283 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $189 |
| GlaxoSmithKline, LLC. | 12 | $156 |
| Verona Pharma, Inc. | 7 | $154 |
| CSL Behring | 8 | $144 |
| Viatris Specialty LLC | 5 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Insmed, Inc. | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Ohtuvayre, BREZTRI, GLASSIA, YUPELRI, CUVITRU.
Industry payments across SD — which companies pay providers there.
